A. Wartel-Tram

Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy

Y. Girerd-Chambaz, C. Simmons, N. Jackson, 2017, eLife.

Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore

B. Guy, J. Lang, L. Shek, 2013, Human vaccines & immunotherapeutics.

Priming effect of dengue and yellow fever vaccination on the immunogenicity, infectivity, and safety of a tetravalent dengue vaccine in humans.

J. Lang, D. Shaw, R. Forrat, 2011, The American journal of tropical medicine and hygiene.